Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Visionary Pharmaceuticals

Visionary Pharmaceuticals
2010 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
2 INVESTORS
Description

Developer of drugs for cancer treatment. The company operates a biotechnology company which develops drugs for medical needs for cancer and inflammation treatement.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 11555 Sorrento Valley Road
  • Suite A
  • San Diego, CA 92121
  • United States

+1 (858) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Visionary Pharmaceuticals’s full profile, request a free trial.

Visionary Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 05-Mar-2013 Completed Startup
2. Accelerator/Incubator 17-Sep-2012 Completed Startup
1. Seed Round 27-Jul-2011 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Visionary Pharmaceuticals Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
The National Institute of Diabetes and Digestive and Kidney Diseases Government 000 0000 000000 0
CONNECT (Accelerator) Accelerator/Incubator Minority 000 0000 000000 0

Visionary Pharmaceuticals Executive Team (3)

Name Title Board
Seat
Contact
Info
Gordon Alton Ph.D Co-Founder, Chief Executive Officer, President & Director
Louis Tommasino Chief Financial Officer
Ayse Batova Ph.D Co-Founder, Vice President of Biology & Director

Visionary Pharmaceuticals Board Members (1)

Name Representing Role Since Contact
Info
John Westwick Ph.D Self Board Member 000 0000